JHL Biotech's Final Trading Day on Taipei Exchange Feb 11, 2018 07:00PM
JHL Biotech's Application to Voluntarily Terminate Trading of Shares Approved by Taipei Exchange Feb 3, 2018 11:29AM
JHL Biotech Shareholders Vote to Voluntarily Delist from Taiwan Exchange Feb 1, 2018 09:00AM
JHL Biotech Welcomes New Chief Medical Officer, Rong Chen Jan 1, 2018 07:30AM
JHL Biotech Submits Clinical Trial Application in Europe for Proposed Dornase Alfa Biosimilar to Affordably Manage Symptoms of Cystic Fibrosis Dec 20, 2017 01:29PM


Dec 20, 2017 10:17AM JHL Biotech Submits Clinical Trial Application in Europe for Proposed Bevacizumab Biosimilar to Treat Colorectal, Lung, and Ovarian Cancers
Apr 4, 2017 08:00PM China FDA Accepts JHL's First Clinical Trial Application
Mar 29, 2017 03:05AM JHL Doses First Patient In JHL1101 Phase I European Trial
Feb 29, 2016 06:45PM JHL Biotech and Affinita Biotech Agree to Partner in the Development and Manufacturing of Oncology Monoclonal Antibodies
Feb 25, 2016 04:00AM JHL Biotech Announces Mechanical Completion of its Wuhan Biopharmaceutical Manufacturing Facility
Feb 14, 2016 07:00PM JHL Biotech Receives Approval From European Authorities to Begin Biosimilar Clinical Trial
Oct 20, 2015 04:00AM JHL Biotech Appoints New Leaders to Management Team
Oct 2, 2015 01:26PM JHL Biotech Lists on the Taiwan Emerging Stock Board